
Global Sarcopenia Treatment Market - Industry Trends and Forecast to 2030
Description
Global Sarcopenia Treatment Market - Industry Trends and Forecast to 2030
The global sarcopenia treatment market is expected to reach USD 4,043,993.94 thousand by 2030 from USD 2,770,500.00 thousand in 2022, growing at a CAGR of 4.9% in the forecast period of 2023 to 2030.
Market Segmentation
Global Sarcopenia Treatment Market, By Treatment Type (Medications, Vitamin/Dietary Supplements, and Others), Type (Primary Sarcopenia and Secondary Sarcopenia), Stages (Pre-Sarcopenia, Sarcopenia, and Severe Sarcopenia), Route Of Administration (Oral, Injectable, and Others), Gender (Male and Female), End User (Hospitals, Specialty Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country ( U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Denmark, Norway, Sweden, Poland, Finland, and Rest Of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, New Zealand, Taiwan, And Rest Of Asia-Pacific, Brazil, Argentina, and Rest Of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Oman, Qatar, Bahrain, and Rest Of Middle East and Africa) - Industry Trends and Forecast to 2030
Overview of Global Sarcopenia Treatment Market Dynamics
Driver
• Rising prevalence of sarcopenia
Restraint
• Lack of standardized diagnosis
Opportunity
• Strategic initiatives by key market players
Market Players
Some of the key market players operating in the global sarcopenia treatment market are listed below:
• Abbott,
• Nestlé Health Science (A subsidiary of Nestlé S.A.),
• Novartis AG
• Sanofi
• Haleon Group of Companies
• BASF SE
• DSM
• Fermenta Biotech Limited
• AstaReal Co., Ltd.
• Metagenics
• BioThrive Sciences.
• Wellona Pharma
• The Vitamin Company India
• Biogen SA
• Healing Pharma India Pvt. Ltd
• Others
Table of Contents
468 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The Global Sarcopenia Treatment Market
- 1.4 Currency And Pricing
- 1.5 Limitations
- 1.6 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Dbmr Tripod Data Validation Model
- 2.5 Primary Interviews With Key Opinion Leaders
- 2.6 Multivariate Modelling
- 2.7 Treatment Type Segment Lifeline Curve
- 2.8 Market End User Coverage Grid
- 2.9 Dbmr Market Position Grid
- 2.10 Vendor Share Analysis
- 2.11 Secondary Sources
- 2.12 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestel Analysis
- 4.2 Porter’s Five Forces Model
- 4.3 Current Status Of Emerging Drugs For Sarcopenia Treatment
- 5 Global Sarcopenia Treatment Market: Regulations
- 5.1 Regulations In U.S.
- 5.2 Regulations In Europe
- 5.3 Regulations In Australia
- 5.4 Regulations In South Africa
- 6 Market Overview
- 6.1 Drivers
- 6.1.1 Rising Prevalence Of Sarcopenia
- 6.1.2 Growing Awareness Of Sarcopenia And Its Detrimental Effects On Health
- 6.1.3 Lifestyle Factors Such As Poor Nutrition And Sedentary Behaviour
- 6.2 Restraints
- 6.2.1 Lack Of Standardized Diagnosis
- 6.2.2 High Cost Of Treatment And Interventions
- 6.3 Opportunities
- 6.3.1 Strategic Initiatives By Market Players
- 6.3.2 Increasing Research And Development Activities
- 6.4 Challenges
- 6.4.1 Complications Associated With The Sarcopenia Treatment
- 6.4.2 Stringent Government Rules And Regulation For Product Approval
- 7 Global Sarcopenia Treatment Market, By Treatment Type
- 7.1 Overview
- 7.2 Vitamin/Dietary Supplements
- 7.2.1 Vitamin Supplements
- 7.2.2 Protein Supplements
- 7.2.3 Fatty Acid Supplements
- 7.2.4 Creatine
- 7.2.5 Whey Proteins
- 7.2.6 L-carnitine
- 7.2.7 Soy
- 7.2.8 Beta-alanine
- 7.2.9 Ostarine
- 7.2.10 Collagen Peptides
- 7.2.11 Ligandrol
- 7.2.12 Branch-chain Amino Acids
- 7.2.13 Hydroxymethylbutyrate (Hmb)
- 7.2.14 Medium Chain Triglycerides
- 7.2.15 Others
- 7.3 Medications
- 7.3.1 Off Label Drugs
- 7.3.2 Emerging Drugs
- 7.3.2.1 Ace Inhibitors
- 7.3.2.2 Appetite Stimulants
- 7.3.2.3 Oral Antidiabetic Drugs
- 7.3.2.4 Others
- 7.4 Others
- 8 Global Sarcopenia Treatment Market, By Type
- 8.1 Overview
- 8.2 Primary Sarcopenia
- 8.2.1 Vitamin/Dietary Supplements
- 8.2.2 Medications
- 8.2.3 Others
- 8.3 Secondary Sarcopenia
- 8.3.1 Vitamin/Dietary Supplements
- 8.3.2 Medications
- 8.3.3 Others
- 9 Global Sarcopenia Treatment Market, By Stages
- 9.1 Overview
- 9.2 Pre-sarcopenia
- 9.3 Sarcopenia
- 9.4 Severe Sarcopenia
- 10 Global Sarcopenia Treatment Market, By Route Of Administration
- 10.1 Overview
- 10.2 Oral
- 10.3 Injectables
- 10.4 Others
- 11 Global Sarcopenia Treatment Market, By Gender
- 11.1 Overview
- 11.2 Male
- 11.3 Female
- 12 Global Sarcopenia Treatment Market, By End User
- 12.1 Overview
- 12.2 Hospitals
- 12.2.1 Public
- 12.2.2 Private
- 12.3 Specialty Clinics
- 12.4 Home Healthcare
- 12.5 Others
- 13 Global Sarcopenia Treatment Market, By Distribution Channel
- 13.1 Overview
- 13.2 Direct Tender
- 13.3 Retail Sales
- 13.3.1 Hospital Pharmacies
- 13.3.2 Online Pharmacies
- 13.3.3 Others
- 13.4 Others
- 14 Global Sarcopenia Treatment Market, By Region
- 14.1 Overview
- 14.2 North America
- 14.2.1 U.S.
- 14.2.2 Canada
- 14.2.3 Mexico
- 14.3 Europe
- 14.3.1 Germany
- 14.3.2 France
- 14.3.3 U.K.
- 14.3.4 Italy
- 14.3.5 Spain
- 14.3.6 Russia
- 14.3.7 Turkey
- 14.3.8 Belgium
- 14.3.9 Netherlands
- 14.3.10 Switzerland
- 14.3.11 Denmark
- 14.3.12 Norway
- 14.3.13 Sweden
- 14.3.14 Poland
- 14.3.15 Finland
- 14.3.16 Rest Of Europe
- 14.4 Asia-pacific
- 14.4.1 Japan
- 14.4.2 China
- 14.4.3 South Korea
- 14.4.4 India
- 14.4.5 Australia
- 14.4.6 Singapore
- 14.4.7 Thailand
- 14.4.8 Malaysia
- 14.4.9 Indonesia
- 14.4.10 Philippines
- 14.4.11 Vietnam
- 14.4.12 New Zealand
- 14.4.13 Taiwan
- 14.4.14 Rest Of Asia-pacific
- 14.5 South America
- 14.5.1 Brazil
- 14.5.2 Argentina
- 14.5.3 Rest Of South America
- 14.6 Middle East And Africa
- 14.6.1 South Africa
- 14.6.2 Saudi Arabia
- 14.6.3 U.A.E
- 14.6.4 Egypt
- 14.6.5 Israel
- 14.6.6 Oman
- 14.6.7 Qatar
- 14.6.8 Bahrain
- 14.6.9 Rest Of Middle East And Africa
- 15 Global Sarcopenia Treatment Market, Company Landscape
- 15.1 Company Share Analysis: Global
- 15.2 Company Share Analysis: North America
- 15.3 Company Share Analysis: Europe
- 15.4 Company Share Analysis: Asia-pacific
- 16 Swot Analysis
- 17 Company Profile
- 17.1 Abbott
- 17.1.1 Company Snapshot
- 17.1.2 Revenue Analysis
- 17.1.3 Company Share Analysis
- 17.1.4 Product Portfolio
- 17.1.5 Recent Development
- 17.2 Nestlé Health Science (A Subsidiary Of Nestlé S.A.)
- 17.2.1 Company Snapshot
- 17.2.2 Revenue Analysis
- 17.2.3 Company Share Analysis
- 17.2.4 Product Portfolio
- 17.2.5 Recent Development
- 17.3 Novartis Ag
- 17.3.1 Company Snapshot
- 17.3.2 Revenue Analysis
- 17.3.3 Company Share Analysis
- 17.3.4 Product Portfolio
- 17.3.5 Pipeline Portfolio
- 17.3.6 Recent Development
- 17.4 Sanofi
- 17.4.1 Company Snapshot
- 17.4.2 Revenue Analysis
- 17.4.3 Company Share Analysis
- 17.4.4 Product Portfolio
- 17.4.5 Recent Development
- 17.5 Haleon Group Of Companies.
- 17.5.1 Company Snapshot
- 17.5.2 Revenue Analysis
- 17.5.3 Company Share Analysis
- 17.5.4 Product Portfolio
- 17.5.5 Recent Development
- 17.6 Astareal Co., Ltd.
- 17.6.1 Company Snapshot
- 17.6.2 Product Portfolio
- 17.6.3 Recent Development
- 17.7 Basf Se
- 17.7.1 Company Snapshot
- 17.7.2 Revenue Analysis
- 17.7.3 Product Portfolio
- 17.7.4 Recent Development
- 17.8 Biogen Sa
- 17.8.1 Company Snapshot
- 17.8.2 Product Portfolio
- 17.8.3 Recent Development
- 17.9 Biothrive Sciences
- 17.9.1 Company Snapshot
- 17.9.2 Product Portfolio
- 17.9.3 Recent Development
- 17.10 Dsm
- 17.10.1 Company Snapshot
- 17.10.2 Revenue Analysis
- 17.10.3 Product Portfolio
- 17.10.4 Recent Development
- 17.11 Fermenta Biotech Limited
- 17.11.1 Company Snapshot
- 17.11.2 Revenue Analysis
- 17.11.3 Product Portfolio
- 17.11.4 Recent Development
- 17.12 Healing Pharma India Pvt. Ltd.
- 17.12.1 Company Snapshot
- 17.12.2 Product Portfolio
- 17.12.3 Recent Development
- 17.13 Metagenics
- 17.13.1 Company Snapshot
- 17.13.2 Product Portfolio
- 17.13.3 Recent Development
- 17.14 The Vitamin Company India
- 17.14.1 Company Snapshot
- 17.14.2 Product Portfolio
- 17.14.3 Recent Development
- 17.15 Wellona Pharma
- 17.15.1 Company Snapshot
- 17.15.2 Product Portfolio
- 17.15.3 Recent Development
- 17.16 Armgo Pharma, Inc.
- 17.16.1 Company Snapshot
- 17.16.2 Pipeline Portfolio
- 17.16.3 Recent Development
- 17.17 Biophytis
- 17.17.1 Company Snapshot
- 17.17.2 Pipeline Portfolio
- 17.17.3 Recent Development
- 17.18 Dystrogen Therapeutics Corp
- 17.18.1 Company Snapshot
- 17.18.2 Pipeline Portfolio
- 17.18.3 Recent Development
- 17.19 Immunoforge Inc.
- 17.19.1 Company Snapshot
- 17.19.2 Pipeline Portfolio
- 17.19.3 Recent Development
- 17.20 Mymd Pharmaceuticals
- 17.20.1 Company Snapshot
- 17.20.2 Pipeline Portfolio
- 17.20.3 Recent Development
- 17.21 Nmd Pharma A/S
- 17.21.1 Company Snapshot
- 17.21.2 Pipeline Portfolio
- 17.21.3 Recent Development
- 17.22 Oncocross Co., Ltd.
- 17.22.1 Company Snapshot
- 17.22.2 Pipeline Portfolio
- 17.22.3 Recent Development
- 17.23 Opko Health, Inc.
- 17.23.1 Company Snapshot
- 17.23.2 Revenue Analysis
- 17.23.3 Pipeline Portfolio
- 17.23.4 Recent Development
- 17.24 Regeneron Pharmaceuticals Inc.
- 17.24.1 Company Snapshot
- 17.24.2 Revenue Analysis
- 17.24.3 Pipeline Portfolio
- 17.24.4 Recent Development
- 17.25 Rejuvenate Biomed Nv
- 17.25.1 Company Snapshot
- 17.25.2 Pipeline Portfolio
- 17.25.3 Recent Development
- 18 Questionnaire
- 19 Related Reports
- List Of Tables
- Table 1 Current Status Of The Development Of Drug For Sarcopenia Treatment
- Table 2 Global Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 3 Global Vitamin/Dietary Supplements In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 4 Global Vitamin/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 5 Global Medications In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 6 Global Medicatinons In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 7 Global Off-lable Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 8 Global Others In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 9 Global Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 10 Global Primary Sarcopenia In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 11 Global Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 12 Global Secondary Sarcopenia In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 13 Global Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 14 Global Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand)
- Table 15 Global Pre-sarcopenia In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 16 Global Sarcopenia In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 17 Global Severe Sarcopenia In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 18 Global Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 19 Global Oral In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 20 Global Injectables In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 21 Global Others In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 22 Global Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand)
- Table 23 Global Male In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 24 Global Female In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 25 Global Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand)
- Table 26 Global Hospitals In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 27 Global Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 28 Global Specialty Clinics In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 29 Global Home Healthcare In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 30 Global Others In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 31 Global Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 32 Global Direct Tender In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 33 Global Retail Sales In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 34 Global Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 35 Global Others In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 36 Global Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 37 North America Sarcopenia Treatment Market, By Country, 2021-2030 (Usd Thousand)
- Table 38 North America Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 39 North America Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 40 North America Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 41 North America Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume)
- Table 42 North America Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 43 North America Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 44 North America Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 45 North America Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 46 North America Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand)
- Table 47 North America Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 48 North America Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand)
- Table 49 North America Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand)
- Table 50 North America Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 51 North America Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 52 North America Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 53 U.S. Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 54 U.S. Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 55 U.S. Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 56 U.S. Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume)
- Table 57 U.S. Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Asp)
- Table 58 U.S. Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 59 U.S. Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 60 U.S. Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 61 U.S. Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 62 U.S. Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand)
- Table 63 U.S. Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 64 U.S. Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand)
- Table 65 U.S. Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand)
- Table 66 U.S. Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 67 U.S. Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 68 U.S. Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 69 Canada Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 70 Canada Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 71 Canada Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 72 Canada Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume)
- Table 73 Canada Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Asp)
- Table 74 Canada Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 75 Canada Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 76 Canada Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 77 Canada Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 78 Canada Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand)
- Table 79 Canada Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 80 Canada Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand)
- Table 81 Canada Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand)
- Table 82 Canada Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 83 Canada Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 84 Canada Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 85 Mexico Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 86 Mexico Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 87 Mexico Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 88 Mexico Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume)
- Table 89 Mexico Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Asp)
- Table 90 Mexico Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 91 Mexico Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 92 Mexico Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 93 Mexico Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 94 Mexico Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand)
- Table 95 Mexico Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 96 Mexico Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand)
- Table 97 Mexico Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand)
- Table 98 Mexico Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 99 Mexico Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 100 Mexico Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 101 Europe Sarcopenia Treatment Market, By Country, 2021-2030 (Usd Thousand)
- Table 102 Europe Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 103 Europe Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 104 Europe Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 105 Europe Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume)
- Table 106 Europe Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 107 Europe Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 108 Europe Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 109 Europe Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 110 Europe Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand)
- Table 111 Europe Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 112 Europe Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand)
- Table 113 Europe Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand)
- Table 114 Europe Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 115 Europe Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 116 Europe Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 117 Germany Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 118 Germany Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 119 Germany Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 120 Germany Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume)
- Table 121 Germany Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Asp)
- Table 122 Germany Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 123 Germany Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 124 Germany Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 125 Germany Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 126 Germany Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand)
- Table 127 Germany Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 128 Germany Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand)
- Table 129 Germany Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand)
- Table 130 Germany Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 131 Germany Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 132 Germany Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 133 France Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 134 France Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 135 France Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 136 France Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume)
- Table 137 France Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Asp)
- Table 138 France Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- Table 139 France Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 140 France Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 141 France Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 142 France Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand)
- Table 143 France Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 144 France Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand)
- Table 145 France Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand)
- Table 146 France Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 147 France Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 148 France Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 149 U.K. Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
- List Of Figures
- Figure 1 Global Sarcopenia Treatment Market: Segmentation
- Figure 2 Global Sarcopenia Treatment Market: Data Triangulation
- Figure 3 Global Sarcopenia Treatment Market: Droc Analysis
- Figure 4 Global Sarcopenia Treatment Market: Global Vs Regional Market Analysis
- Figure 5 Global Sarcopenia Treatment Market: Company Research Analysis
- Figure 6 Global Sarcopenia Treatment Market: Interview Demographics
- Figure 7 Global Sarcopenia Treatment Market: Market End Users Coverage Grid
- Figure 8 Global Sarcopenia Treatment Market: Dbmr Market Position Grid
- Figure 9 Global Sarcopenia Treatment Market: Vendor Share Analysis
- Figure 10 Global Sarcopenia Treatment Market: Segmentation
- Figure 11 The Rising Prevalence Of Sarcopenia And Growing Awareness Of Sarcoepnia And Its Detrimental Effect On Health Are Expected To Drive The Growth Of The Global Sarcopenia Treatment Market From 2023 To 2030
- Figure 12 Vitamin/Dietary Supplements Segment Is Expected To Account For The Largest Share Of The Global Preclinical Market In 2023 And 2030
- Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Global Sarcopenia Treatment Market
- Figure 14 Global Sarcopenia Treatment Market: By Treatment Type, 2022
- Figure 15 Global Sarcopenia Treatment Market: By Treatment Type, 2023-2030 (Usd Thousand)
- Figure 16 Global Sarcopenia Treatment Market: By Treatment Type, Cagr (2023-2030)
- Figure 17 Global Sarcopenia Treatment Market: By Treatment, Lifeline Curve
- Figure 18 Global Sarcopenia Treatment Market: By Type, 2022
- Figure 19 Global Sarcopenia Treatment Market: By Type, 2023-2030 (Usd Thousand)
- Figure 20 Global Sarcopenia Treatment Market: By Type, Cagr (2023-2030)
- Figure 21 Global Sarcopenia Treatment Market: By Type, Lifeline Curve
- Figure 22 Global Sarcopenia Treatment Market: By Stages, 2022
- Figure 23 Global Sarcopenia Treatment Market: By Stages, 2023-2030 (Usd Thousand)
- Figure 24 Global Sarcopenia Treatment Market: By Stages, Cagr (2023-2030)
- Figure 25 Global Sarcopenia Treatment Market: By Stages, Lifeline Curve
- Figure 26 Global Sarcopenia Treatment Market: By Route Of Administration, 2022
- Figure 27 Global Sarcopenia Treatment Market: By Route Of Administration (2023-2030)
- Figure 28 Global Sarcopenia Treatment Market: By Route Of Administration (2023-2030)
- Figure 29 Global Sarcopenia Treatment Market: Lifeline Curve
- Figure 30 Global Sarcopenia Treatment Market: By Gender, 2022
- Figure 31 Global Sarcopenia Treatment Market: By Gender, 2023-2030 (Usd Thousand)
- Figure 32 Global Sarcopenia Treatment Market: By Gender, Cagr (2023-2030)
- Figure 33 Global Sarcopenia Treatment Market: By Gender, Lifeline Curve
- Figure 34 Global Sarcopenia Treatment Market: By End User, 2022
- Figure 35 Global Sarcopenia Treatment Market: By End User, 2023-2030 (Usd Thousand)
- Figure 36 Global Sarcopenia Treatment Market: By End User, Cagr (2023-2030)
- Figure 37 Global Sarcopenia Treatment Market: By End User, Lifeline Curve
- Figure 38 Global Sarcopenia Treatment Market: By Distribution Channel, 2022
- Figure 39 Global Sarcopenia Treatment Market: By Distribution Channel, 2023-2030 (Usd Thousand)
- Figure 40 Global Sarcopenia Treatment Market: By Distribution Channel, 2023-2030 (Usd Thousand)
- Figure 41 Global Sarcopenia Treatment Market: By Distribution Channel, 2023-2030 (Usd Thousand)
- Figure 42 Global
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.